CD4 and neoplasm: Of note, Foxp3+ Tregs did not efficiently infiltrate into the lung compared with effector CD4+ T cells (Supplemental Figure 4A), while tumor-infiltrating Treg cells highly expressed ICOS regardless of host age or anti–PD-L1 therapy (Supplemental Figure 4B).